BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 32273627)

  • 1. Association between locomotive syndrome and the Japanese version of the EQ-5D-5L in middle-aged and elderly people in Japan.
    Tanaka S; Ando K; Kobayashi K; Seki T; Hamada T; Machino M; Ota K; Morozumi M; Kanbara S; Ito S; Ishiguro N; Hasegawa Y; Imagama S
    Nagoya J Med Sci; 2020 Feb; 82(1):5-14. PubMed ID: 32273627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dual presence of frailty and locomotive syndrome is associated with a greater decrease in the EQ-5D-5L index.
    Tanaka S; Ando K; Kobayashi K; Nakashima H; Seki T; Ishizuka S; Machino M; Morozumi M; Kanbara S; Ito S; Kanemura T; Ishiguro N; Hasegawa Y; Imagama S
    Nagoya J Med Sci; 2021 Feb; 83(1):159-167. PubMed ID: 33727747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between "loco-check" and EuroQol, a comprehensive instrument for assessing health-related quality of life: a study of the Japanese general population.
    Iizuka Y; Iizuka H; Mieda T; Tajika T; Yamamoto A; Takagishi K
    J Orthop Sci; 2014 Sep; 19(5):786-91. PubMed ID: 25023927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affirmative answers on loco-check as a predictor of health-related quality of life and locomotive syndrome progression in the elderly: A cross-sectional study.
    Shigematsu H; Tanaka M; Munemoto M; Kawasaki S; Iwata E; Okuda A; Masuda K; Yamamoto Y; Suga Y; Tanaka Y
    Mod Rheumatol; 2020 May; 30(3):580-585. PubMed ID: 31116048
    [No Abstract]   [Full Text] [Related]  

  • 5. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.
    Feng Y; Herdman M; van Nooten F; Cleeland C; Parkin D; Ikeda S; Igarashi A; Devlin NJ
    Qual Life Res; 2017 Aug; 26(8):2067-2078. PubMed ID: 28343350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients.
    Mugii N; Someya F; Noto S; Hamaguchi Y; Matsushita T; Takehara K
    Mod Rheumatol; 2020 Jul; 30(4):681-686. PubMed ID: 31269847
    [No Abstract]   [Full Text] [Related]  

  • 7. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese Population Norms of EQ-5D-5L and Health Utilities Index Mark 3: Disutility Catalog by Disease and Symptom in Community Settings.
    Shiroiwa T; Noto S; Fukuda T
    Value Health; 2021 Aug; 24(8):1193-1202. PubMed ID: 34372985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of preference- and profile-based quality of life of Japanese oral cancer patients during the perioperative period measured using EQ-5D-5L and FACT-H&N.
    Aoki T; Ota Y; Izawa K; Osawa Y; Seta S; Tsuda B
    Int J Oral Maxillofac Surg; 2022 Aug; 51(8):992-999. PubMed ID: 34551875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.
    Greene ME; Rader KA; Garellick G; Malchau H; Freiberg AA; Rolfson O
    Clin Orthop Relat Res; 2015 Nov; 473(11):3383-90. PubMed ID: 25488404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
    Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
    Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linguistic and Psychometric Validation of the Cognition Bolt-On Version of the Japanese EQ-5D-5L for the Elderly.
    Igarashi A; Sakata Y; Azuma-Kasai M; Kamiyama H; Kawaguchi M; Tomita K; Ishii M; Ikeda M
    J Alzheimers Dis; 2023; 91(4):1447-1458. PubMed ID: 36641680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y; Devlin N; Herdman M
    Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
    McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
    Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
    Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
    Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.
    Shiroiwa T; Fukuda T; Ikeda S; Igarashi A; Noto S; Saito S; Shimozuma K
    Qual Life Res; 2016 Mar; 25(3):707-19. PubMed ID: 26303761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy.
    Hirose C; Fujii H; Iihara H; Ishihara M; Nawa-Nishigaki M; Kato-Hayashi H; Ohata K; Sekiya K; Kitahora M; Matsuhashi N; Takahashi T; Okuda K; Naruse M; Ishihara T; Sugiyama T; Yoshida K; Suzuki A
    Support Care Cancer; 2020 Dec; 28(12):5943-5952. PubMed ID: 32281034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P.
    Murasawa H; Sugiyama T; Matsuoka Y; Okabe T; Hino A; Tanaka N; Sugimoto M; Oyama M; Fujimoto K; Horie S; Noto S; Shimozuma K
    Qual Life Res; 2019 Sep; 28(9):2383-2391. PubMed ID: 31025290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic survey of locomotive syndrome in Japan.
    Seichi A; Kimura A; Konno S; Yabuki S
    J Orthop Sci; 2016 Mar; 21(2):222-5. PubMed ID: 26806332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.